GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mad2 who wrote (2029)	1/15/2000 10:01:00 PM
From: out_of_the_loop	Read Replies (1) of 5582

Geez. Pleconaril has been known about for over a year. Yawn. Pleconaril: 1.cost - $50-$100 per "cold treatment" 2. Effectiveness - cold duration down from 14 to 10 days. 3. prescription. 4. no prevention proof. Zicam: 1. cost - less than $5 per cold 2. effectiveness - cold duration down from 10-14 days to 1-3 days 3. nonprescription 4. prevention studies will be out long before VPHM will get FDA approval. Pleconaril is not a threat to Zicam except for those with imaginations and unappreciative of reality. We have discussed it here before. Several weeks ago Agouron was out with publicity on their drug. This weekend VPHM is stepping up their publicity on pleconaril. GUMM will have data out on Zicam prophylaxis way before either make any real sales. Zicam has its place in the OTC market. Pleconaril will have its place in the treatment of meningitis and some viral inffections but Dr. Romero must really be the Joker if he thinks it is a cure for the common cold. If you really think it will take away the otc market, short away, but anyone with any sense will take a sub-$10 otc remedy that works better and does not require a doctor's visit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next